Melanoma Clinical Trials in Dallas

Showing 121-129 of 129 trials

A Study of Volociximab in Metastatic Melanoma

NCT00369395

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.

Stage IV Melanoma

Abbott19 participantsStarted Dec 2006

Scottsdale, Arizona, United States • La Jolla, California, United States • Aurora, Colorado, United States +4 more locations

COMPLETEDPHASE1< 1 mile

Study of XL281 in Adults With Solid Tumors

NCT00451880

The purpose of this study is to determine the safest dose of the multiple Raf kinase inhibitor (including c-Raf, B-Raf, and the activated mutant B-RafV600E) XL281, how often it should be taken, and how well subjects with cancer tolerate XL281. This study will also determine how the body reacts to XL281 when it is taken with and without food, and with and without Pepcid (famotidine), a drug that inhibits stomach acid production.

CancerNon-small-cell Lung CancerColorectal Cancer+2 more

Exelixis180 participantsStarted Feb 2007

Scottsdale, Arizona, United States • Tampa, Florida, United States • Detroit, Michigan, United States +3 more locations

A Study of Volociximab in Metastatic Melanoma

Study of XL281 in Adults With Solid Tumors

Melanoma Trials in Other Cities

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

CP-675,206 In Patients With Advanced Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Other Conditions in Dallas